id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-P-4039-0003,FDA,FDA-2017-P-4039,Interim Response Letter from FDA CDER to Center for Lawful Access and Abuse Deterrence,Other,Letter(s),2017-12-28T05:00:00Z,2017,12,2017-12-28T05:00:00Z,,2017-12-28T21:28:04Z,,0,0,0900006482d7f298
FDA-2017-P-4039-0002,FDA,FDA-2017-P-4039,Acknowledgment Letter from FDA DDM to Center for Lawful Access and Abuse Deterrence,Other,Acknowledgement Letter/Receipt,2017-07-03T04:00:00Z,2017,7,2017-07-03T04:00:00Z,,2017-07-03T16:19:40Z,,0,0,09000064827dee8e
FDA-2017-P-4039-0001,FDA,FDA-2017-P-4039,Citizen Petition from Center for Lawful Access and Abuse Deterrance,Other,Citizen Petition,2017-07-03T04:00:00Z,2017,7,2017-07-03T04:00:00Z,,2017-07-10T15:32:24Z,,0,0,09000064827deb78